Bacteremic community-acquired pneumonia in Ethiopian children : etiology, antibiotic resistance, risk factors, and clinical outcome by Negash, Abel Abera et al.
M A J O R  A R T I C L E
Bacteremic CAP in Ethiopian Children • ofid • 1
Open Forum Infectious Diseases
 
Received 2 October 2018; editorial decision 15 January 2019; accepted 16 January 2019.
Correspondence: A. A. Negash, MSc, Armauer Hansen Research Institute, P.O. Box 1005, 
Addis Ababa, Ethiopia (abelishasweet@yahoo.com).
Open Forum Infectious Diseases®
© The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases 
Society of America. This is an Open Access article distributed under the terms of the Creative 
Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/
by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any 
medium, provided the original work is not altered or transformed in any way, and that the 
work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
DOI: 10.1093/ofid/ofz029
Bacteremic Community-Acquired Pneumonia in 
Ethiopian Children: Etiology, Antibiotic Resistance, Risk 
Factors, and Clinical Outcome
Abel Abera Negash,1,5,  Daniel Asrat,2 Workeabeba Abebe,3 Tewodros Hailemariam,4 Tsegaye Hailu,1 Abraham Aseffa,1 and Mario Vaneechoutte5
1Armauer Hansen Research Institute, Addis Ababa, Ethiopia; 2Department of Microbiology and Immunology and 3Department of Pediatrics and Child Health, School of Medicine, Addis Ababa 
University, Addis Ababa, Ethiopia; 4Department of Pediatrics and Child Health, Yekatit 12 Medical College, Addis Ababa, Ethiopia; 5Laboratory Bacteriology Research, Department of Diagnostic 
Sciences, Faculty of Medicine & Health Sciences, Ghent University, Ghent, Belgium
Background. Community-acquired pneumonia (CAP) remains a leading cause of morbidity and mortality. We sought to deter-
mine the magnitude, etiology, and risk factors of CAP in children 5 years after introduction of pneumococcal conjugate vaccine 
(PCV) 10 in Ethiopia.
Methods. We conducted a prospective observational study on the bacterial etiology and risk factors of CAP among children 
aged 0–15 years in 2 pediatric emergency departments in Addis Ababa, Ethiopia. Blood culture, antibiotic susceptibility testing, and 
amplification of pneumococcal lytA and cpsB genes were performed. Serotypes of Streptococcus pneumoniae were determined by 
Quellung reaction and sequencing the cpsB gene.
Results. Out of 643 eligible children, 549 were enrolled. The prevalence of bacteremic pneumonia was 5.6%. Staphylococcus 
aureus (26.5%) was the predominant pathogenic species, followed by Enterococcus faecium (11.8%), Escherichia coli (11.8%), and 
Klebsiella pneumoniae (11.8%). In univariate analysis, parental smoking and nonvaccination with PCV10 were associated with bacte-
remic CAP. In multivariable analysis, female sex (adjusted odds ratio [aOR], 2.3; 95% confidence interval [CI], 1.1–4.9), weight-for-
age z-score (WAZ) <–2 SDs (aOR, 2.2; 95% CI, 1.1–4.8), and lower chest indrawing (aOR, 0.44; 95% CI, 0.2–0.95) were independently 
associated with bacteremic CAP. The overall in-hospital case fatality rate was 2.37% (13/549), and WAZ <–3 SDs (OR, 13.5; 95% CI, 
3.95–46.12) was associated with mortality.
Conclusions. Five years after the introduction of PCV10 in Ethiopia, S. aureus was the main cause of bacteremic CAP in chil-
dren, the contribution of S. pneumoniae was low, and there was a high level of antibiotic resistance among isolates.
Keywords. bacteremic community-acquired pneumonia; Ethiopia; PCV10; Staphylococcus aureus; Streptococcus pneumoniae.
Community-acquired pneumonia (CAP) remains a leading 
cause of morbidity and mortality worldwide. In 2015, there 
were an estimated 138 million (95% uncertainty interval [UI], 
86–226 million) episodes of clinical pneumonia and 0.9 mil-
lion (95% UI, 0.8–1.1 million) pneumonia deaths in children 
younger than 5  years. Half of all deaths occurred in India, 
Nigeria, Pakistan, Democratic Republic of Congo, and Ethiopia. 
The 5 countries with the highest mortality rates were all in 
sub-Saharan Africa [1].
The incidence of radiologically confirmed pneumonia 
has been substantially reduced as a result of the widespread 
introduction of pneumococcal conjugate vaccine (PCV) and 
Haemophilus influenzae type B (Hib) conjugate vaccine. The Hib 
vaccine has led to an 18% decrease in radiologically confirmed 
pneumonia [2], whereas the PCV efficacy trial in Gambia has 
indicated a 37% reduction in radiologically confirmed pneumo-
nia cases [3].
Before the introduction of conjugate vaccines, Streptococcus 
pneumoniae and Hib were the leading bacterial causes of pneu-
monia, while Staphylococcus aureus and Klebsiella pneumoniae 
were associated with more severe cases. Due to an increased 
coverage of PCV and Hib conjugate vaccines, recent studies on 
the etiology of pneumonia indicate a changing profile of patho-
gens, which are mixed viral/bacterial infections [4].
Childhood pneumonia and associated severe clinical man-
ifestations are a result of the complex interaction between the 
host, the pathogen, and environmental risk factors. The most 
common risk factors that affect the incidence of childhood CAP 
in developing countries are malnutrition, low birth weight, non-
exclusive breastfeeding, lack of measles immunization, indoor 
air pollution, and crowding [5].
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Although only a minority of patients with pneumonia have 
documented blood stream infections, blood culture is still an 
important tool for diagnosis of pneumonia [6]. The World 
Health Organization (WHO) guidelines for the management of 
CAP in children recommend treatment of CAP and severe CAP 
with antibiotics to limit progression to severe or very severe 
CAP and the associated mortality [7]. Despite the challenges, it 
remains important to determine the etiology of CAP, consider-
ing the rise in antimicrobial resistance and the potential epide-
miological impact of conjugate vaccines.
Most of the studies on childhood pneumonia in Ethiopia 
have focused on sociodemographic risk factors and the prev-
alence of CAP. Community-level prevalence rates of 16.1% 
[8] and 33.5% [9] have been reported. Risk factors associated 
with CAP in Ethiopian children are malnutrition, charcoal use 
for cooking, lack of exclusive breastfeeding in the first year of 
life, and overcrowding [8, 9]. There are, however, no data on 
the etiology of bacteremic CAP in Ethiopian children. PCV10 
was introduced in Ethiopia in 2011 [10]. This study was there-
fore performed to determine the magnitude, etiology, and risk 
factors of bacteremic CAP in Ethiopian children and the role 
of S. pneumoniae in causing bacteremic pneumococcal CAP in 
children 5 years after the introduction of PCV10 in Ethiopia.
METHODS
Study Setting and Design
The study was carried out in the pediatric emergency departments 
(PEDs) of 2 large hospitals in Addis Ababa, Ethiopia: the Tikur 
Anbessa Specialized Hospital (TASH) and the Yekatit 12 Hospital.
Patient Recruitment, Data Collection, and Follow-up
We carried out a prospective observational study from September 
1, 2016, to August 30, 2017. All children between the ages 0 to 
15  years presenting to the 2 PEDs with CAP and who fulfilled 
the following criteria were recruited: (1) cough and/or dyspnea, 
and/or (2) radiological confirmation of pneumonia by the attending 
radiologist according to WHO guidelines [11], (3) first symptoms 
appearing within the last 2 weeks, and (4) no intake of antibiotics, 
with no hospital or health care admissions in the 2 weeks before the 
current admission. Tachypnea was defined as respiratory rate ≥60/
min in children <2  months; ≥50/min in children 2–12  months; 
≥40/min in children ≥1–5 years; and ≥20/min in children >5 years 
[12, 13]. Trained research nurses approached parents/guardians of 
children who fulfilled the criteria during the study period. A struc-
tured questionnaire was used to obtain sociodemographic and 
other relevant clinical data. The final outcome was registered, and 
length of stay in the hospital was recorded in days.
Laboratory Procedures
Sample Collection
At enrollment, venous blood (1  mL for <1-month-old and 
2–5 mL for >1-month-old children) was drawn aseptically and 
transferred into 20  mL of Brain Heart Infusion (BHI) broth 
(Oxoid, Cheshire, England) bottles and mixed gently by invert-
ing the bottle. In addition, 1–2  mL of blood, collected using 
ethylenediaminetetraacetic acid (EDTA) vials, was available 
for 273 children and was frozen at –80°C for polymerase chain 
reaction (PCR).
Culture and Identification
The inoculated BHI was cultured aerobically. After 24 hours 
of incubation, Gram stain was carried out, followed by sub-
culture on blood agar, chocolate agar, and MacConkey agar 
(Oxoid). Culture bottles that did not show growth were further 
incubated for 7  days and subcultured before being reported 
negative. Initial identification of bacteria was carried out at 
the Armauer Hansen Research Institute (AHRI), Addis Ababa, 
Ethiopia, by Gram stain, hemolytic activity on sheep blood agar 
plates, optochin sensitivity, bile solubility, coagulase test, colony 
morphology on MacConkey agar, and growth on mannitol salt 
agar. Further identification was then performed on all isolates 
by Matrix-assisted laser desorption/ionization time of flight 
mass spectrometry (MALDI-TOF MS) at Ghent University, 
Ghent, Belgium.
Antibiotic Susceptibility Testing
Antibiotic susceptibility testing on a selected panel of antibi-
otics that are used locally was done using the Kirby-Bauer disk 
diffusion method [14] and interpreted according to the Clinical 
and Laboratory Standard Institute (CLSI) criteria [15]. The fol-
lowing reference strains were used as controls: Escherichia coli 
ATCC 25922, S. aureus ATCC 25923, and S. pneumoniae ATCC 
49619.
DNA Extraction
DNA extraction from S.  pneumoniae isolates was carried 
out by alkaline lysis as described previously [16]. For DNA 
extraction from whole blood, initial pretreatment of the sam-
ples was performed as described elsewhere [17]. Briefly, 100 μL 
of whole-blood EDTA was added to 100 μL of Tris-EDTA buffer 
containing 75 U/mL of mutanolysin (Sigma Chemical Co., St. 
Louis, MO), and the mixture was incubated for 1 hour at 37°C. 
DNA extraction was then carried out with the DNeasy 96 Blood 
& Tissue Kit (Qiagen, Venlo, the Netherlands), according to the 
manufacturer’s instructions.
Amplification of cpsB and lytA
Primers used to amplify 1061 bp of the cpsB gene (encoding 
for phosphotyrosine phosphatase) were forward primer cps1-FP 
(5’-GCAATGCCAGACAGTAACCTCTAT-3’) and 2 reverse 
primers, cps2-RP (5’-CCTGCCTGCAAGTCTTGATT-3’) and 
cps-2538-RP (5’-CTTTACCAACCTT TGTAATCCAT-3’), 
and the PCR reaction was performed as described previously 
[18]. Amplification of a 101-bp fragment of the lytA gene was 
carried out as previously described [19], using the primers 
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lytA F (5’-ACGCAATCTAGCAGATGAAGCA-3’) and lytA R 
(5’-TCGTGCGTTTTAATTCCAGCT-3’). The PCR amplicons 
were analyzed with 1.0% agarose gel electrophoresis.
Sequencing and Serotyping
Twenty microliters of the amplicons was sent for sequencing 
to GATC Biotech (Constance, Germany), and sequencing was 
performed using the Sanger sequencing technique. cpsB gene 
sequences were used to interrogate GenBank database (http://
www.ncbi.nlm.nih.gov/blast). Serotype was assigned based 
on a BLAST bit score of >99% sequence identity of the query 
cpsB nucleotide sequence with the reference sequences from 
GenBank. Serotyping was also performed by Quellung reaction 
using type-specific antisera.
Statistical Analysis
Data were initially entered in ReDCap (Vanderbilt University, 
Nashville, TN), exported into Excel, and analyzed using PASW 
Statistics 20 software (SPSS Inc., Chicago, IL). Descriptive 
statistics were used to analyze sociodemographic and clini-
cal characteristics. Continuous variables were expressed in 
terms of mean ± SD and median (interquartile range [IQR]), 
whereas categorical variables were expressed in frequencies and 
percentages. The chi-square test for categorical variables and 
Mann-Whitney U test for continuous variables were performed 
to compare descriptive data between bacteremic and nonbac-
teremic children. To identify variables associated with bacte-
remic CAP, bivariate analysis using binary logistic regression 
was performed. Variables significant at P <  .1 were then used 
in a multivariable model to identify independent associations. 
Variables in the multivariable model were considered signifi-
cant at P < .05. Results from the logistic regression analyses are 
reported as odds ratios (ORs) and adjusted ORs (aORs) with 
95% confidence intervals (CIs).
Ethical Approval
The study was approved by the AHRI/All Africa Leprosy 
Rehabilitation and Training Hospital (ALERT) Ethics Review 
Committee, Addis Ababa University Institutional Review Board, 
Yekatit 12 Medical College Ethics Committee, and the National 
Research Ethics Review Committee (No. 310/194/2017). 
The parents and/or guardians of all participants gave written 
informed consent.
RESULTS
Characteristics of the Study Population
Blood for culture and complete sociodemographic and clini-
cal data were obtained from 549 out of the 643 children who 
fulfilled the inclusion criteria during the study period. Among 
the 549 children enrolled, 321 (58.5%) were males. Among 
children with bacteremia (31), most (61.3%) were females 
(P  =  .022) (Table 1). The median age of children (IQR) was 
9 months (IQR 3–18), and most of the children (93.7%) were 
infants. Although parental smoking was reported in only 18 
(3.3%) of the children, bacteremia was seen in a significantly 
higher percentage of the children who were exposed to smok-
ing (16.7%) than in those who were not (5.3%; P = .039).
The most common clinical presentation of the children was 
cough (93.1%), followed by fever (92.3%) and tachypnea (87.4%) 
(Table 2). Bacteria were isolated from significantly more of the 
children without signs of lower chest indrawing (9.7%) than 
from those with signs of lower chest indrawing (4.3%; P = .019). 
A chest radiograph was performed in 68 children, and pneumo-
nia was radiologically confirmed in 55 (80.9%) of them. Full-
dose PCV10 vaccination had been given to 484 (88%) of the 
children. Bacterial pathogens were isolated in significantly more 
children who were unvaccinated with PCV10 than those who 
had received at least 1 dose of PCV10 (14.3% vs 5.2%; P = .042). 
Weight-for-age z-score (WAZ) was between –2 and –3 SDs in 49 
(8.1%) and was less than –3 SDs in 71 (12.9%) of the children.
Etiology
A pathogen was identified in 34 of 549 (6.19%) blood cultures, 
of which 31 (91.18%) were positive for bacteria and 3 (8.82%) 
were positive for fungi (Table 3). The most commonly isolated 
pathogens were S.  aureus (26.5%), E.  faecium (11.8%), E.  coli 
(11.8%), and K. pneumoniae (11.8%). S. pneumoniae was iso-
lated from only 1 of the blood cultures. The following bacte-
rial species, which we designated as probable pathogens, were 
isolated from 5.3% (29/549) of blood cultures: Streptococcus 
oralis (n = 8), Kocuria spp. (n = 5), Micrococcus luteus (n = 4), 
Pantoea agglomerans (n  =  2), Streptococcus parasanguinis 
(n = 2), Arthrobacter oxydans (n = 1), Bacillus cereus (n = 1), 
Brachybacterium faecium (n  =  1), Enterococcus raffinosus 
(n  =  1), Exiguobacterium aurantiacum (n  =  1), Lysinibacillus 
fusiformis (n = 1), Streptococcus infantis (n = 1), Streptococcus 
mitis (n = 1), Streptococcus pseudopneumoniae (n = 1). In addi-
tion, coagulase-negative staphylococci were isolated from 28 
(5.1%) of the blood cultures.
Antibiotic Susceptibility Testing
Most of the bacterial isolates (64.5%) were Gram-negative, and 
all except Proteus mirabilis were resistant to 2 or more antibiot-
ics (Table 4). All 4 Enterococcus faecium isolates were resistant 
to amoxicillin, penicillin, erythromycin, and tetracycline. All 3 
K. pneumoniae isolates were resistant to amoxicillin, ceftriaxone, 
erythromycin, and gentamicin. Among Gram-positives, all 9 
S. aureus isolates were resistant to penicillin, and 5 were resistant 
to tetracycline. Methicillin resistance, which was determined 
using cefoxitin discs, was observed in 3 of the S. aureus isolates.
Serotyping and lytA PCR
Out of 273 whole-blood samples on which lytA PCR was per-
formed, a positive result was obtained in only 2 cases, 1 of which 
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was also blood culture–positive. The pneumococcus isolated 
from blood culture could not be assigned to a specific serotype 
on the basis of PCRSeqTyping and was 35A/B/C/F, 33A/C/F. It 
was then assigned to serotype 33A by means of the Quellung 
reaction. The serotype of the additional pneumococcus that 
was detected by lytA PCR was serotype 24, as determined by 
PCRSeqTyping.
Predictors of Bacteremic Community-Acquired Pneumonia
Female children were more likely to have bacteremic CAP than 
males (aOR, 2.3; 95% CI, 1.1–4.9; P  =  .032). Children who 
were malnourished (WAZ <–2 SDs) were more likely to have 
bacteremic CAP than those who were well-nourished (aOR, 
2.2; 95% CI, 1.1–4.8; P  =  .047). Children with signs of lower 
chest indrawing were less likely to have bacteremic CAP than 
those without signs of lower chest indrawing (aOR, 0.44; 95% 
CI, 0.2–0.95; P = .037) (Table 5).
Mortality
The overall in-hospital case fatality rate was 2.37% (13/549). 
The etiology of fatal pneumonia was determined in only 3 of 
these cases. The organisms that were isolated from the children 
who died were S. aureus, K. pneumoniae, and Kocuria kristinae. 
The median length of stay of the children who died (IQR) was 
Table 1. Comparison of Sociodemographic and Environmental Risk Factors Among Children Aged 0–15 Years With Bacteremic and Nonbacteremic CAP
Variable Category
All Children
(n = 549)
Bacteremic 
(n = 31)
Nonbacteremic
(n = 518)
No. (%) No. (%) No. (%) P a
Gender Male 321 (58.5)b 12 (3.7) 309 (96.3) .022
Female 228 (41.5) 19 (8.3) 209 (91.7)  
Age <28 d 5 (0.9) 0 (0.0) 5 (0.9) .441
28 d–1 y 441 (80.3) 28 (6.3) 413 (93.7)  
2–5 y 89 (16.2) 2 (2.2) 87 (97.8)  
≥6 y 14 (2.6) 1 (7.1) 13 (92.9)  
Premature birth Yes 93 (16.9) 4 (4.3) 89 (95.7) .537
Birth weight <2.5 Kg 62 (11.3) 6 (9.7) 56 (90.3) .144
≥2.5 Kg 487 (88.7) 25 (5.1) 462 (94.9)  
No. of household members ≤ 3 164 (29.9) 7 (4.3) 157 (95.7) .659
4–6 336 (61.2) 21 (6.2) 315 (93.8)  
≥ 7 49 (8.9) 3 (6.1) 46 (93.9)  
No. of rooms in the house 1 157 (28.6) 8 (5.1) 149 (94.9) .723
≥ 2 392 (71.4) 23 (5.9) 369 (94.1)  
Has siblings aged <5 y Yes 108 (19.7) 7 (6.5) 101 (93.5) .675
Day care/preschool attendance Yes 57 (10.4) 3 (5.3) 54 (94.7) .895
Breastfeeding Yes 337 (61.4) 22 (6.5) 315 (93.5) .259
Mothers age, median (IQR), y  29 (26–33) 31 (28–34) 29 (26–33) .597
Mother’s level of education Illiterate 92 (16.8) 3 (3.3) 89 (96.7) .713
Primary 163 (29.7) 11 (6.7) 152 (93.3)  
Secondary 158 (28.8) 9 (5.7) 149 (94.3)  
College and above 136 (24.8) 8 (5.9) 128 (94.1)  
Fathers level of education Illiterate 42 (7.7) 2 (4.8) 40 (95.2) .378
Primary 128 (23.3) 4 (3.1) 124 (96.9)  
Secondary 151 (27.5) 12 (7.9) 139 (92.1)  
College & above 228 (41.5 13 (5.7) 215 (94.3)  
Monthly income <1000 birr (45 $) 91 (16.6) 7 (7.7) 84 (92.3) .572
(45–136 $) 321 (58.5) 15 (4.7) 306 (95.3)  
(136–227 $) 93 (16.9) 7 (7.5) 86 (92.5)  
(227 $) 44 (8) 2 (4.5) 42 (95.5)  
Parental smoking Yes 18 (3.3) 3 (16.7) 15 (83.3) .039
Cooking fuel Firewood 99 (18) 2 (2) 97 (98) .084
Charcoal 335 (61) 21 (6.3) 314 (93.7) .430
Electricity 311 (56.6) 19 (6.1) 292 (93.9) .591
Gas 37 (6.7) 2 (5.4) 35 (94.6) .948
Cooking performed in living rooms Yes 317 (57.7) 19 (61.3) 12 (38.7) .68
Abbreviation: CAP, community-acquired pneumonia.
aP value of chi-square test for categorical variables and Mann-Whitney U for continuous variables; those in bold are significant at P < .05.
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2 days (IQR 1–3). Nutritional status was the only variable that 
was associated with mortality. Children who were severely mal-
nourished (WAZ <–3 SDs) were 13.5 times more likely to die 
than those who were not (95% CI, 3.95–46.12; P < .001).
DISCUSSION
To our knowledge, this is the first study in Ethiopia that 
describes bacteremic CAP in children. The main findings of 
the study are (1) the prevalence of bacteremic CAP was 5.6% 
(out of 549 cases of CAP); (2) the most common isolate was 
S.  aureus, and there was only 1 S.  pneumoniae isolate, with 1 
additional case as determined by S. pneumoniae–specific PCR; 
(3) in univariate analysis by chi-square, parental smoking and 
nonvaccination with PCV10 were associated with bacteremic 
CAP; (4) multivariable analysis revealed that female sex and 
malnutrition were associated with an increased bacteremic 
CAP, whereas lower chest indrawing was associated with 
decreased bacteremic CAP; and (5) malnutrition was positively 
associated with mortality.
In this study, the prevalence of bacteremic pneumonia in 
a population of Ethiopian children, of whom 88.2% were fully 
PCV-vaccinated, was 5.6%. Other reports mention prevalences of 
4.1% in a PCV-vaccinated population in Austria [20], and 6.7% in 
Mali [21] and 6.9% in Kenya [22] for nonvaccinated populations.
In our study, S. aureus, at 26.5% (9/34), was the most com-
mon isolate. A study on the vaccine-naïve pediatric population 
Table 2. Comparison of Clinical Characteristics and Risk Factors Among Children Aged 0–15 Years With Bacteremic and Nonbacteremic CAP
Variable Category
All Children
(n = 549)
Bacteremic 
(n = 31)
Nonbacteremic
(n = 518)
No. (%) No. (%) No. (%) P a
URTI in the last 3 mo Yes 89 (16.2) 6 (6.7) 83 (93.3) .625
LRTI in the last 3 mo Yes 105 (19.1) 9 (8.6) 96 (91.4) .149
Previous hospital admission Yes 92 (16.8) 5 (5.4) 87 (94.6) .923
Days since onset of symptoms ≤3 260 (47.4) 11 (4.2) 249 (95.8) .336
4–6 249 (45.4) 18 (7.2) 231 (92.8)  
≥7 40 (7.3) 2 (5) 38 (95)  
Sign and symptoms Fever 507 (92.3) 30 (5.9) 477 (94.1) .340
Cough 511 (93.1) 27 (5.3) 484 (94.7) .177
Dyspnea 310 (56.5) 22 (7.1) 288 (92.9) .094
Tachypnea 480 (87.4) 25 (5.2) 455 (94.8) .241
Chest pain 119 (21.7) 9 (7.6) 110 (92.4) .306
Rales 317 (57.7) 15 (4.7) 302 (95.3) .278
Wheezing 346 (63) 18 (5.2) 328 (94.8) .556
Lower chest indrawing 415 (75.6) 18 (4.3) 397 (95.7) .019
Nasal flaring 383 (69.8) 22 (5.7) 361 (94.3) .881
Inability to breastfeed 129 (23.5) 9 (7) 120 (93) .454
Vomiting 264 (48.1) 15 (5.7) 249 (94.3) .973
Convulsion 16 (2.9) 2 (12.5) 14 (87.5) .228
Lethargy 42 (7.7) 5 (11.9) 37 (88.1) .067
Radiologically confirmed  55 (80.9)b 2 (3.6) 53 (96.4) .496
Vaccination with PCV10 Vaccinatedc 521 (94.9) 27 (5.2) 494 (94.8) .042
1st dose 8 (1.5) 0 (0.0) 8 (100)  
2nd dose 29 (5.3) 2 (6.9) 27 (93.1)  
3rd (full) dose 484 (88.2) 25 (5.2) 459 (94.8)  
Nonvaccinated 28 (5.1) 4 (14.3) 24 (85.7)  
Nutritionald status Malnourishedd 120 (21.9) 11 (9.2) 109 (21.0) .059
Moderately 49 (8.9) 4 (8.2) 45 (91.8)  
Severely 71 (12.9) 7 (9.9) 64 (90.1)  
Well-nourished 429 (78.1) 20 (4.7) 409 (95.3)  
Length of stay, median (IQR), d  2 (1–3) 2 (2–3) 2 (1–3) .788
Final outcome Died 13 (2.4) 2 (15.4) 11 (84.6) .124
Discharged or transferred 536 (97.6) 29 (5.4) 507 (94.6)  
Abbreviations: CAP, community-acquired pneumonia; LRTI, lower respiratory tract infection; PCV, pneumococcal conjugate vaccine; URTI, upper respiratory tract infection.
aP value of chi-square test for categorical variables and Mann-Whitney U for continuous variables; those in bold are significant at P < .05.
bRadiologically confirmed cases; for 55 (80.9%) out of the 68, a chest radiograph was performed.
cVaccinated with at least 1 dose of PCV10.
dWorld Health Organization child growth standard of weight-for-age z-score was used to determine nutritional status. Accordingly, well-nourished: z-score ≥ –2.0 <; moderately malnourished: 
–3.0 < z-score < –2.0; severely malnourished: z-score < –3.0.
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in India also identified S.  aureus (33.3%, 15/45) as the most 
common cause of bacteremic CAP [23]. Results of a study on 
nonbacteremic CAP in Ethiopian children before the intro-
duction of PCV10 indicated that S. pneumoniae (14.3%) and 
Streptococcus  pyogenes were the most common isolates, fol-
lowed by S.  aureus (12.5%) [24]. Although it is difficult to 
extrapolate findings from bacteremic CAP into nonbacteremic 
CAP and vice versa, some inferences could be made. In a pre-
PCV study on the etiology of CAP in Kenya by Hammit and 
colleagues, S. pneumonie was the most common isolate from 
both blood culture and induced sputum (IS). Blood culture was 
positive in only 6 (10%) of 63 children with a positive IS cul-
ture, and of 5 children with pneumococcal bacteremia, S. pneu-
moniae was isolated in the IS culture of only 2 [22]. It has not 
been elucidated whether a similar trend exists for S.  aureus. 
A recent report by Hammit and colleagues indicated an 85% 
decline in the incidence of bacteremic pneumococcal pneu-
monia in Kenya [25]. It is therefore important to assess the 
role of S. aureus in both bacteremic and nonbacteremic CAP 
in Ethiopia in relation to a possible decline in the incidence 
of pneumococcal bacteremic and nonbacteremic CAP in the 
post-PCV period.
We ascertained the distinction between CAP and hospi-
tal-acquired pneumonia (HAP) using Centers for Disease 
Control and Prevention criteria [26]. S. pneumoniae, H. influ-
enzae, S.  aureus, and K.  pneumoniae, which cause CAP [4], 
can also cause early-onset (occurring within the first 4  days 
of hospitalization) HAP and its subtype, ventilator-associated 
pneumonia (VAP). Late-onset HAP/VAP, which are associated 
with high rates of morbidity and mortality, are often caused 
by multidrug-resistant (MDR) pathogens such as S.  aureus, 
Pseudomonas aeruginosa, K. pneumoniae, and Enterobacter spp. 
[27].
 We were able to isolate S. pneumoniae from only 1 blood cul-
ture, and lytA PCR detected 1 more case. Before the introduc-
tion of PCV, a bacteremic pneumococcal pneumonia prevalence 
of up to 7.2% was reported in Mali [28]. Moïsi and colleagues 
have been able to show a 3-fold increase in detection of pneumo-
coccal bacteremia using lytA PCR compared with blood culture 
Table 4. Antibiotic Susceptibility of Pathogenic Bacterial Blood Culture Isolates From Children With Community-Acquired Pneumonia
Antibiotics  P AML AMC CRO E TE SXT CN C CIP FOX
Species Total No. No.a No.a No.a No.a No.a No.a No.a No.a No.a No.a No.a
Gram-positive
Staphylococcus aureus 9 9 - - - 3 5 1 2 0 1 3
Staphylococcus lugdunensis 1 1 - - - 1 1 0 0 0 1 -
Streptococcus pneumoniae 1 0 - - - 0 1 1 - 0 - -
Gram-negative            -
Enterococcus faecium 4 4 4 - - 4 4 - - 1 0 -
Escherichia coli 3 - 0 0 0 1 1 0 0 0 0 -
Klebsiella pneumoniae 3 - 3 1 3 3 1 2 3 2 2 -
Pseudomonas spp. 3 - 3 2 2 2 0 2 0 1 0 -
Moraxella cattarhalis 2 - - 0 1 2 0 0 - 1 0 -
Acinetobater baumanni 1 1 1 1 1 - 0 1 0 - 0 -
Burkholderia cepaciab 1 - - - - - - - - - - -
Citrobacter koseri 1 - 1 1 1 1 1 1 0 - 0 -
Haemophilus influenzae 1 - 1 1 1 1 1 0 - 1 1 -
Proteus mirabilis 1 - 0 0 0 0 1 0 0 0 0 -
Abbreviations: -, not tested; AML, amoxicillin; AMC, amoxicillin, clavulanate; C, chloramphenicol; CIP, ciprofloxacin; CN, gentamicin; CRO, ceftriaxone; E, erythromycin; FOX, cefoxitin; P, 
penicillin; SXT, trimethoprim/sulfamethoxazole; TE, tetracycline.
aNumber of resistant isolates.
bHas been performed, but disc diffusion interpretative breakpoints are not available.
Table 3. Etiology of Community-Acquired Pneumonia in Children Aged 
0–15 Years
Species No. %
Known pathogens 34
Bacteria 31  
Staphylococcus aureus 9 26.5
Enterococcus faecium 4 11.8
Escherichia coli 3 8.8
Klebsiella pneumoniae 3 8.8
Pseudomonas spp. 3 5.9
Moraxella catarrhalis 2 5.9
Acinetobacter baumanni 1 2.9
Burkholderia cepacia 1 2.9
Citrobacter koseri 1 2.9
Haemophilus influenzae 1 2.9
Proteus mirabilis 1 2.9
Staphylococcus lugdunensis 1 2.9
Streptococcus pneumoniae 1 2.9
Fungi 3  
Candida albicans 1 2.9
Candida parapsilosis 2 5.9
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during the prevaccination period in Mali [17]. Our results, 
which indicate only insignificant enhancement of detection by 
lytA PCR, might be a reflection of the current prevalence of bac-
teremic pneumococcal pneumonia 5 years after the introduction 
of PCV10 in Ethiopia. Unfortunately, due to the lack of pre-PCV 
vaccination data on the prevalence of bacteremic pneumococcal 
pneumonia in Ethiopia, comparisons could not be made.
Our findings indicate that most of the bacterial isolates were 
resistant to first- and second-line antibiotics used to treat CAP in 
children. There was also a high level of multidrug resistance, with 
E. faecium and K. pneumoniae being 100% resistant to 4 antibiotics 
each. Studies indicate that there is a trend of increasing antimicro-
bial resistance in Ethiopia [29]. The standard treatment guideline 
in Ethiopia suggests the use of chloramphenicol in case of lack of 
response to trimethoprim-sulphamethaxozole, amoxicillin, and 
bezylpenicillin. With only 25% resistance of E.  faecium against 
chloramphenicol in our study, it could still be used as a treatment 
option [30]. In the case of MDR K. pneumoniae, the use of pipera-
cillin-tazobactam, moropenem, and impenem-cilastatin has been 
suggested [31]. Our results highlight the need for incorporation 
of improved diagnostic tools and antimicrobial resistance surveil-
lance to aid the choice of antibiotics.
The case fatality rate in our study (2.37%) was lower than 
results from a non-PCV population in Mali (4.2%) [21] and a 
multihospital, retrospective cohort study in Kenya (5%) 3 years 
after introduction of PCV10 in the country [32].
Several risk factors associated with bacteremic CAP in 
Ethiopian children have been identified in our study through 
univariate and multivariable analyses. A  significantly higher 
percentage of children who had a parent that smokes had bac-
teremic CAP than those without. Although there are no studies 
that describe the relationship between parental smoking and 
bacteremic CAP, parental smoking and environmental tobacco 
exposure have been associated with pneumonia [33].
Bacteremic CAP was observed in significantly more of the 
children who were not vaccinated with PCV10 compared with 
those who had received at least 1 dose of PCV10. Tagarro and 
colleagues have been able to show that due to the introduc-
tion of PCV13 in Madrid, Spain, bacteremic CAP declined 
from 7.9/100 000 children in 2009 to 2.1/100 000 children in 
2012. The incidence of bacteremic CAP then increased again 
to 5.4/100 000 children in 2014, 2 years after the withdrawal of 
PCV13 from the universal vaccination program [34].
Female sex was significantly associated with isolation of 
pathogenic bacteria from blood cultures of children with CAP, 
with female children being 2.3 times more likely to have bac-
teremic CAP than male children. Although male sex has been 
associated with higher pneumonia incidence and hospitaliza-
tion [35], there is no evidence in the literature for the associ-
ation between gender and bacteremic pneumonia in children. 
However, Isaacman and colleagues have reported increased risk 
of bacteremia in febrile female children [36].
In this study, children with signs of lower chest indrawing 
were less likely to have bacteremic CAP than those without. 
Lower chest indrawing is one of the main signs that is used to 
classify pneumonia [12] and has been identified as a sign of 
potentially fatal pneumonia [32]. In a study performed by De 
Santis and colleagues in Tanzania, lower chest indrawing was 
found to be associated with viral disease [37]. Although clini-
cal presentation of viral diseases is thought to be milder than 
that of bacterial diseases, at present most acute respiratory 
infections in children in well-vaccinated populations are due to 
viruses rather than bacteria, even in children with a more severe 
presentation [37, 38].
In our study, children with pneumonia who were malnour-
ished were 2.2 times more likely to have bacteremic pneumo-
nia, and those who were severely malnourished were 13.5 times 
more likely to die due to pneumonia than well-nourished chil-
dren. WAZ <–3 SDs has been identified as a clinically important 
risk of death in a recent report from Kenya [32].
Our study had some limitations. Although we only tried to 
include children who did not receive antibiotics during the 2 
weeks preceding sampling, there might still have been cases of 
empiric antibiotic treatment. The low volume of blood obtained 
in some children might also have affected culture positivity. 
Limitations in proper transport and storage of whole blood might 
have also affected the results of lytA PCR. Although both emer-
gency departments accept patients coming from home, many of 
the cases in the hospitals are referrals, and our results might not 
be representative of the true prevalence of CAP in Addis Ababa.
Table 5. Factors Associated With Bacteremic Community-Acquired Pneumonia in Children Aged 0–15 Years
Variable 
Bivariate Multivariable
OR (CI) P aOR (CI) P a
Female sex 2.34 (1.1–4.9) .025 2.3 (1.1–4.9) .032
Malnourished 2.1 (0.96–4.4) .064 2.2 (1.1–4.8) .047
Lower chest indrawing 0.42 (0.2–0.89) .023 0.44 (0.2–0.95) .037
Vaccination with PCV10 0.33 (0.11–1.01) .053 2.6 (0.8–8.1) .11
Parental smoking 3.6 (0.98–13.1) .053 3.2 (0.83–12.4) .91
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; OR, odds ratio; PCV, pneumococcal conjugate vaccine.
aP value of multivariable logistic regression analyses; those in bold are significant at P < .05. Dow
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CONCLUSIONS
This study has described the sociodemographic and clinical 
predictors of bacteremia in Ethiopian children with CAP. Five 
years after the introduction of PCV10 in Ethiopia, S. aureus was 
the main etiological agent of bacteremic CAP, and the contri-
bution of S. pneumoniae was low. Most of the bacterial isolates 
were resistant to first- and second-line antibiotics to treat CAP, 
which indicates a need for incorporation of improved diagnostic 
tools and antimicrobial resistance surveillance to aid the choice 
of antibiotics. Parental smoking, nonvaccination with PCV10, 
female sex, malnutrition, and absence of chest indrawing were 
associated with bacteremic CAP. Malnutrition was associated 
with mortality due to CAP.
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